Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Other Non-Current Liabilities: 2020-2023

Historic Other Non-Current Liabilities for Legend Biotech (LEGN) over the last 4 years, with Dec 2023 value amounting to $56,000.

  • Legend Biotech's Other Non-Current Liabilities rose 28117.24% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 28117.24%. This contributed to the annual value of $56,000 for FY2023, which is 75.97% down from last year.
  • As of FY2023, Legend Biotech's Other Non-Current Liabilities stood at $56,000, which was down 75.97% from $233,000 recorded in FY2022.
  • In the past 5 years, Legend Biotech's Other Non-Current Liabilities registered a high of $554,000 during FY2020, and its lowest value of $56,000 during FY2023.
  • In the last 3 years, Legend Biotech's Other Non-Current Liabilities had a median value of $233,000 in 2022 and averaged $228,333.
  • Data for Legend Biotech's Other Non-Current Liabilities shows a maximum YoY slumped of 75.97% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Legend Biotech's Other Non-Current Liabilities stood at $554,000 in 2020, then dropped by 28.52% to $396,000 in 2021, then crashed by 41.16% to $233,000 in 2022, then slumped by 75.97% to $56,000 in 2023.